| Dr Isadore M Pike, MD | |
|
105 N Summit St, Fairhope, AL 36532-2521 | |
| (251) 990-3098 | |
| (251) 990-3417 |
| Full Name | Dr Isadore M Pike |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 105 N Summit St, Fairhope, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063508083 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 00025872 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Isadore M Pike, MD 105 N Summit St, Fairhope, AL 36532-2521 Ph: (251) 990-3098 | Dr Isadore M Pike, MD 105 N Summit St, Fairhope, AL 36532-2521 Ph: (251) 990-3098 |
News Archive
Caffeine consumption in children is often blamed for sleep problems and bedwetting. Information on childhood caffeine consumption is limited, and many parents may not know the amount or effects of their child's caffeine consumption. In a study published in The Journal of Pediatrics, researchers found that 75% of children surveyed consumed caffeine on a daily basis, and the more caffeine the children consumed, the less they slept.
Two NJIT biomedical researchers have received the prestigious Coulter Foundation Translational Awards for promising patent applications that may some day extend peoples' lives.The Coulter program provides funding for professors in established biomedical engineering departments within the U.S. Initial funding for each professor will be at least $200,000 over a two-year period.
Cell Therapeutics, Inc. ("CTI") announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London during a session at the 2009 American Society of Hematology ("ASH") Annual Meeting updated results from the pivotal phase III EXTEND (PIX 301) clinical trial of pixantrone (the "PIX 301 EXTEND trial") in relapsed or refractory, aggressive non-Hodgkin's lymphoma ("NHL") patients who have failed 2 or more prior therapies.
Patients with drug-resistant epilepsy run the risk of gradual deterioration in their cognitive abilities. Surgical treatment generally puts an end to seizures but can have a negative effect on memory. However, there is no further deterioration in memory, and some patients may even recover some of their memory capacity, reveals a thesis from the University of Gothenburg.
UC San Francisco researchers have discovered a promising new line of attack against lethal, treatment-resistant prostate cancer. Analysis of hundreds of human prostate tumors revealed that the most aggressive cancers depend on a built-in cellular stress response to put a brake on their own hot-wired physiology.
› Verified 3 days ago
Dr. Michael A. Hennigan, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3 Medical Park, Fairhope, AL 36532 Phone: 251-929-3424 Fax: 251-279-3931 | |
Dr. Christopher Clarke, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3 Medical Park, Fairhope, AL 36532 Phone: 251-929-3424 | |
Dr. Zachary Kyle Clark, MD Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 150 S Ingleside St Ste 6, Fairhope, AL 36532 Phone: 251-990-1740 | |
Steven Philip Wittmer, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 150 S Ingleside St Ste 6, Fairhope, AL 36532 Phone: 251-990-1740 Fax: 251-990-1831 | |
Michaela Bylokova Mcdonald, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 750 Morphy Ave, Fairhope, AL 36532 Phone: 251-279-1529 Fax: 251-279-1192 | |
William F Sullivan, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3 Medical Park Drive, Fairhope, AL 36532 Phone: 251-928-8804 Fax: 251-990-9379 |